Fiche publication
Date publication
mai 2018
Journal
Oncotarget
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BORG Christophe
,
Pr GHIRINGHELLI François
,
Mme TRUNTZER Caroline
,
Dr VINCENT Julie
,
Dr BENGRINE-LEFEVRE Leila
Tous les auteurs :
Aarnink A, Richard C, Truntzer C, Vincent J, Bengrine L, Vienot A, Borg C, Ghiringhelli F
Lien Pubmed
Résumé
The FOLFIRINOX regimen is the standard first-line treatment for advanced pancreatic adenocarcinoma (aPDAC). However, because of its potential toxicity, predictive biomarkers could help clinical decision-making.
Mots clés
FOLFIRINOX, advanced pancreatic carcinoma, biomarker, splenic volume
Référence
Oncotarget. 2018 May 22;9(39):25617-25629
